Study: NCT04104672

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AB680
Description: AB680 is a Cluster of Differentiation (CD)73 Inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AB680
Description: AB680 is a Cluster of Differentiation (CD)73 Inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AB680
Description: AB680 is a Cluster of Differentiation (CD)73 Inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AB680
Description: AB680 is a Cluster of Differentiation (CD)73 Inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AB680
Description: AB680 is a Cluster of Differentiation (CD)73 Inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AB680
Description: AB680 is a Cluster of Differentiation (CD)73 Inhibitor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zimberelimab
Description: Zimberelimab is a fully human immunoglobulin G4 (IgG4) monoclonal antibody targeting human PD-1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zimberelimab
Description: Zimberelimab is a fully human immunoglobulin G4 (IgG4) monoclonal antibody targeting human PD-1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zimberelimab
Description: Zimberelimab is a fully human immunoglobulin G4 (IgG4) monoclonal antibody targeting human PD-1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zimberelimab
Description: Zimberelimab is a fully human immunoglobulin G4 (IgG4) monoclonal antibody targeting human PD-1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is a chemotherapy agent. Chemotherapy agents are medicines that kill cancer cells.